Nuvation Bio
Gregory Wei, Ph.D. RAC, serves as the Associate Director of CMC, Analytical Science and Regulatory Affairs at Nuvation Bio and previously held the same title at AnHeart Therapeutics. Prior experience includes a role as Senior Manager of CMC Regulatory Affairs at Forma Therapeutics and as a Research Scientist at Actavis. Gregory Wei has demonstrated extensive expertise in regulatory affairs and analytical science within the pharmaceutical industry.
This person is not in any teams
This person is not in any offices
Nuvation Bio
2 followers
Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.